Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Last month, the company sold a stake of approximately $3.26bn in Haleon, a UK-based consumer healthcare group. These strategic moves come as Pfizer, under the leadership of CEO Albert Bourla ...

Haleon said in a prospectus filed earlier this week that it could face "possible liabilities" connected with OTC Zantac, although it is in the midst of indemnity negotiations with GSK and Pfizer ...

05:45 BlackRock increases stake in Waterford-based Panadol maker Haleon 05:00 Eithne Shortall: The merits of election posters are debatable, but on balance, I’m in favour of them 05:00 Ashbourne’s Fox ...

A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to ... Subscribe now to see this Premium News article from Alliance News ...

UBS analyst Trung Huynh maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $31.00. The company’s shares closed yesterday at $26.72. Huynh covers the ...

Bank of America Securities analyst Victoria Petrova has maintained their bullish stance on HLN stock, giving a Buy rating on November 4.